Cargando…
Identification of Novel Serum Metabolic Biomarkers as Indicators in the Progression of Intravenous Leiomyomatosis: A High Performance Liquid Chromatography-Tandem Mass Spectrometry-Based Study
BACKGROUND: Intravenous leiomyomatosis (IVL) is a rare estrogen-dependent neoplasm. However, identifiable and reliable biomarkers are still not available for clinical application, especially for the diagnosis and prognosis of the disease. METHODS: In the present study, 30 patients with IVL and 30 he...
Autores principales: | Ge, Zhitong, Feng, Penghui, Zhang, Zijuan, Li, Jianchu, Yu, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297591/ https://www.ncbi.nlm.nih.gov/pubmed/34307370 http://dx.doi.org/10.3389/fcell.2021.695540 |
Ejemplares similares
-
Ultrasound appearance of intravenous leiomyomatosis: A case report
por: Ge, Zhitong, et al.
Publicado: (2019) -
Diagnostic value of contrast-enhanced ultrasound in intravenous leiomyomatosis: a single-center experiences
por: Ge, Zhitong, et al.
Publicado: (2022) -
Measurement of tamsulosin in human serum by liquid chromatography–tandem mass spectrometry()
por: Upreti, Rita, et al.
Publicado: (2013) -
Monitoring the Sphingolipid de novo Synthesis by Stable-Isotope Labeling and Liquid Chromatography-Mass Spectrometry
por: Wigger, Dominik, et al.
Publicado: (2019) -
Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry
por: Hallin, Erik I., et al.
Publicado: (2022)